Diabetology International最新文献_第3页

Frequency and determinants of lipid management target achievement in primary prevention of cardiovascular disease in type 2 diabetes 在 2 型糖尿病心血管疾病一级预防中实现血脂管理目标的频率和决定因素

IF 2.2

Diabetology International Pub Date : 2024-04-02 DOI: 10.1007/s13340-024-00712-x

A. Miya, A. Nakamura, Yuka Suzuki, H. Nomoto, H. Kameda, K. Cho, Tatsuya Atsumi

引用次数: 0

A case of diabetic ketoacidosis with prurigo pigmentosa as a dermadrome 一例糖尿病酮症酸中毒合并色素性瘙痒症的皮肤综合征病例

IF 2.2

Diabetology International Pub Date : 2024-04-01 DOI: 10.1007/s13340-024-00711-y

Sachiko Hiraoka, Muneo Kawasumi

引用次数: 0

Advances in basic research on glucagon and alpha cells. 胰高血糖素和α细胞基础研究的进展。

IF 1.3

Diabetology International Pub Date : 2024-02-26 eCollection Date: 2024-07-01 DOI: 10.1007/s13340-024-00696-8

Yoshitaka Hayashi

{"title":"Advances in basic research on glucagon and alpha cells.","authors":"Yoshitaka Hayashi","doi":"10.1007/s13340-024-00696-8","DOIUrl":"10.1007/s13340-024-00696-8","url":null,"abstract":"The regulation of plasma amino acid levels by glucagon in humans first attracted the attention of researchers in the 1980s. Recent basic research using animal models of glucagon deficiency suggested that a major physiological role of glucagon is the regulation of amino acid metabolism rather than to increase blood glucose levels. In this regard, novel feedback regulatory mechanisms that are mediated by glucagon and amino acids have recently been described between islet alpha cells and the liver. Increasingly, hyperglucagonemia in humans with diabetes and/or nonalcoholic fatty liver diseases is reported to likely be a compensatory response to hepatic glucagon resistance. Severe glucagon resistance due to a glucagon receptor mutation in humans causes hyperaminoacidemia and islet alpha cell expansion combined with pancreatic hypertrophy. Notably, a recent report showed that the restoration of glucagon resistance by liver transplantation resolved not only hyperglucagonemia, but also pancreatic hypertrophy and other metabolic disorders. The mechanisms that regulate islet cell proliferation by amino acids largely remain unelucidated. Clarification of such mechanisms will increase our understanding of the pathophysiology of diseases related to glucagon.","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11291817/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141891543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Effects of simultaneous pancreas and kidney transplantation in Japanese individuals with type 1 diabetes and end-stage kidney disease 日本 1 型糖尿病和终末期肾病患者同时接受胰腺和肾脏移植的效果

IF 2.2

Diabetology International Pub Date : 2024-01-24 DOI: 10.1007/s13340-024-00691-z

T. Mori, Izumi Nyumura, K. Hanai, Tomohiro Shinozaki, Tetsuya Babazono

引用次数: 0

Associations of ALT/AST, a marker of hepatosteatosis, with pulse rate in young women and with blood pressure in middle-aged women independently of abdominal fat accumulation and insulin resistance 作为肝脂肪变性标志物的谷丙转氨酶/谷草转氨酶（ALT/AST）与年轻女性脉搏和中年女性血压的关系与腹部脂肪堆积和胰岛素抵抗无关

IF 2.2

Diabetology International Pub Date : 2024-01-24 DOI: 10.1007/s13340-023-00689-z

Satomi Minato-Inokawa, Ayaka Tsuboi-Kaji, M. Honda, Mika Takeuchi, K. Kitaoka, M. Kurata, Bin Wu, Tsutomu Kazumi, Keisuke Fukuo

引用次数: 0

Mortality in childhood-onset type 1 diabetes mellitus with onset between 1959 and 1996: A population-based study in Hokkaido, Japan 1959年至1996年间发病的儿童型1型糖尿病患者的死亡率：日本北海道人口研究

IF 2.2

Diabetology International Pub Date : 2024-01-24 DOI: 10.1007/s13340-023-00688-0

Nobuo Matsuura, H. Yokomichi, Yoshiya Ito, Shigeru Suzuki, Mie Mochizuki

引用次数: 0

Predictive patterns of lower urinary tract symptoms and bacteriuria in adults with type 2 diabetes 2 型糖尿病成人下尿路症状和菌尿的预测模式

IF 2.2

Diabetology International Pub Date : 2024-01-23 DOI: 10.1007/s13340-023-00687-1

Keiji Sugai, Junko Sasaki, Yuki Wada, Norihiro Shimizu, Takuya Ishikawa, Ketchu Yanagi, Takeshi Hashimoto, Akihiko Tanaka, Hirotsugu Suwanai, Ryo Suzuki, Masato Odawara

引用次数: 0

Impacts of “Diabetes Theater,” a participative educational workshop for health care professionals, on participants: a patient empowerment perspective 糖尿病剧场 "是一个面向医护专业人员的参与式教育讲习班，它对参与者的影响：从增强患者能力的角度看问题

IF 2.2

Diabetology International Pub Date : 2024-01-23 DOI: 10.1007/s13340-024-00692-y

Ryotaro Abe, Kentaro Okazaki, Noriyuki Takahashi, Mina Suematsu, Masafumi Kuzuya

引用次数: 0

Acknowledgement to the Reviewers. 向审稿人致谢。

IF 2.2

Diabetology International Pub Date : 2024-01-12 eCollection Date: 2024-01-01 DOI: 10.1007/s13340-023-00690-6

引用次数: 0

Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: the Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10). 日本 2 型糖尿病患者中糖尿病对称性感觉运动多发性神经病的患病率和特征：日本糖尿病并发症及其预防前瞻性研究（JDCP 研究 10）。

IF 2.2

Diabetology International Pub Date : 2024-01-12 eCollection Date: 2024-01-01 DOI: 10.1007/s13340-023-00678-2

Hideki Kamiya, Tatsuhito Himeno, Atsuko Watarai, Masayuki Baba, Rimei Nishimura, Naoko Tajima, Jiro Nakamura

{"title":"Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: the Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10).","authors":"Hideki Kamiya, Tatsuhito Himeno, Atsuko Watarai, Masayuki Baba, Rimei Nishimura, Naoko Tajima, Jiro Nakamura","doi":"10.1007/s13340-023-00678-2","DOIUrl":"10.1007/s13340-023-00678-2","url":null,"abstract":"Aim/introduction: This study aims to investigate the prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy (DSPN) in patients with type 2 diabetes registered in the Japan Diabetes Complication and its Prevention Prospective (JDCP) study.Materials and methods: In the study, 6338 patients with diabetes who had been treated by diabetes specialists were registered in 2007-2009. Of these, patients with type 2 diabetes who could be evaluated for DSPN were analyzed using t test, chi-square test, and logistic regression analyses. DSPN was diagnosed using the Simple Diagnostic Criteria for Diabetic Polyneuropathy proposed by the Diabetic Neuropathy Study Group in Japan.Results: Of the total participants, 5451 patients (mean age 61.4 years old and duration of diabetes 10.8 years) were analyzed. Based on the criteria, 35.8% of patients were diagnosed with DSPN. The prevalence of sensory symptoms was 25.8%. The following factors increased risk for DSPN: age [odds ratio (OR) 1.57, 95% confidence intervals (CI) 1.42-1.73], duration of diabetes (OR 1.32, 95% CI 1.21-1.43), body mass index (OR 1.19, 95% CI 1.09-1.30), systolic blood pressure (OR 1.06, 95% CI 1.01-1.10), hemoglobin A1c (OR 1.15, 95% CI 1.09-1.22), biguanides (OR 1.22, 95% CI 1.06-1.39), and insulin therapy (OR 1.59, 95% CI 1.36-1.84). The following factors decreased risk for DSPN: total cholesterol (OR 0.98, 95% CI 0.96-1.00) and exercise therapy (OR 0.85, 95% CI 0.73-0.98).Conclusions: The baseline survey clarified the prevalence and characteristics of DSPN in Japanese patients with type 2 diabetes. The survey also revealed the risk factors of DSPN.","PeriodicalId":11340,"journal":{"name":"Diabetology International","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10800318/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139541853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0